Search

Search Bar
01/04/2023 To drain or not to drain in uro-oncological robotic surgery? A systematic review and meta-analysis
Territo, A, Baboudjian, M, Diana, P, Gallioli, A, Verri, P, Uleri, A, Basile, G, Tedde, A, Gaya, JM, Huguet, J, Rodriguez-Faba, O, Sanguedolce, F, Gomez, IS, Molina, RS, Palou, J, Breda, A. To drain or not to drain in uro-oncological robotic surgery? A systematic review and meta-analysis. Minerva Urology And Nephrology. 2023; 75(2)DOI:10.23736/S2724-6051.22.05160-6. PMID:36722161. IF:4.900(Q1/2D).
26/03/2023 Teaching robotic cystectomy: prospective pilot clinical validation of the ERUS training curriculum
Diamand, R, D'Hondt, F, Mjaess, G, Jabbour, T, Dell'Oglio, P, Larcher, A, Moschini, M, Quackels, T, Peltier, A, Assenmacher, G, Wiklund, P, Breda, A, Turri, F, De Groote, R, Mottrie, A, Roumeguere, T, Albisinni, S. Teaching robotic cystectomy: prospective pilot clinical validation of the ERUS training curriculum. BJU INTERNATIONAL. 2023; 132(1)DOI:10.1111/bju.15993. PMID:36815233. IF:3.700(Q1/2D).
22/03/2023 Are weight or age limits for pediatric laparoscopic pyeloplasty? Results of a multicentric study
Reed, F, Recabal, X, Echeverria, P, Braga, LH, Cherian, A, Gatti, JM, Garcia-Aparicio, L, Perez-Bertolez, S, de Badiola, F, Bujons, A, Moldes, JM, Mushtaq, I, Lopez, PJ. Are weight or age limits for pediatric laparoscopic pyeloplasty? Results of a multicentric study. WORLD JOURNAL OF UROLOGY. 2023; 41(6)DOI:10.1007/s00345-023-04359-2. PMID:36947174. IF:2.800(Q2/3D).
17/03/2023 The efficacy of retrograde intra-renal surgery (RIRS) for lower pole stones: results from 2946 patients
Giulioni, C, Castellani, D, Somani, BK, Chew, B, Tailly, T, Keat, WOL, Teoh, JY, Emiliani, E, Chai, CA, Galosi, AB, Ragoori, D, Tanidir, Y, Hamri, SB, Gadzhiev, N, Traxer, O, Gauhar, V. The efficacy of retrograde intra-renal surgery (RIRS) for lower pole stones: results from 2946 patients. WORLD JOURNAL OF UROLOGY. 2023; 41(5)DOI:10.1007/s00345-023-04363-6. PMID:36930255. IF:2.800(Q2/3D).
15/03/2023 Expanding inclusion criteria for active surveillance in intermediate-risk prostate cancer: a machine learning approach
Baboudjian, M, Breda, A, Roumeguere, T, Uleri, A, Roche, JB, Touzani, A, Lacetera, V, Beauval, JB, Diamand, R, Simone, G, Windisch, O, Benamran, D, Fourcade, A, Fiard, G, Durand-Labrunie, C, Roumiguie, M, Sanguedolce, F, Oderda, M, Barret, E, Fromont, G, Dariane, C, Charvet, AL, Gondran-Tellier, B, Bastide, C, Lechevallier, E, Palou, J, Ruffion, A, Van der Bergh, RCN, Peltier, A, Ploussard, G. Expanding inclusion criteria for active surveillance in intermediate-risk prostate cancer: a machine learning approach. WORLD JOURNAL OF UROLOGY. 2023; 41(5)DOI:10.1007/s00345-023-04353-8. PMID:36920491. IF:2.800(Q2/3D).
01/03/2023 Active surveillance in renal transplant patients with prostate cancer: a multicentre analysis
Soeterik T.F.W., van den Bergh R.C.N., van Melick H.H.E., Kelder H., Peretti F., Dariane C., Timsit M.-O., Branchereau J., Mesnard B., Tilki D., Olsburgh J., Kulkarni M., Kasivisvanathan V., Breda A., Biancone L., Gontero P., Gandaglia G., Marra G., Hedli O., Lebacle C., Irani J., Rodriguez-Faba O., Todeschini P., Thibault C., Gaya J.M., Lamanna G., Secchi A.. Active surveillance in renal transplant patients with prostate cancer: a multicentre analysis. WORLD JOURNAL OF UROLOGY. 2023; 41(3)DOI:10.1007/s00345-023-04294-2. PMID:36710292. IF:2.800(Q2/3D).